{"id":980186,"date":"2026-07-09T08:46:01","date_gmt":"2026-07-09T12:46:01","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-ceo-sabrina-martucci-johnson-to-participate-in-virtual-investor-closing-bell-event\/"},"modified":"2026-07-09T08:46:01","modified_gmt":"2026-07-09T12:46:01","slug":"dare-bioscience-ceo-sabrina-martucci-johnson-to-participate-in-virtual-investor-closing-bell-event","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-ceo-sabrina-martucci-johnson-to-participate-in-virtual-investor-closing-bell-event\/","title":{"rendered":"Dar\u00e9 Bioscience CEO, Sabrina Martucci Johnson, to Participate in Virtual Investor Closing Bell Event"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"center\">\n        <em>Live video webcast on Tuesday, July 14<\/em><br \/>\n        <sup><br \/>\n          <em>th<\/em><br \/>\n        <\/sup><br \/>\n        <em>, at 4:00 PM ET<br \/><\/em><br \/>\n        <em>Register <\/em><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=kD9xlV7QZ0Q-oHWMADRpp6yZgUAohGtsa9Qmns9mo1QPlBEI03jOdvuvNe8EsfBFGPdRw7T6TGZ69nmz0P2hJBMfTqFbpxXmPueNhYLmydOhYRGLt-kNinwETtV2Vt5DnzPiPmd8AqX7dMgbFajW5g==\" rel=\"nofollow\" target=\"_blank\"><br \/>\n          <em>here<\/em><br \/>\n        <\/a>\n      <\/p>\n<p align=\"justify\">SAN DIEGO, July  09, 2026  (GLOBE NEWSWIRE) &#8212; Dar\u00e9 Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women&#8217;s health between promising science and real-world solutions, today announced that it will participate in a <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=It8otvHNJbofY8OhlFckeScWeUT2S9iRwdiCNeG92fAVHAqFB2xZOeBWkHhebZknnyDhwpz04J0geGmzTRZsqRl9sE0_ZHWNZhzF25y-Fr2pn2fs70dCPj3uaXbHRe3oLpi6SViC3Ic_aCEXYpMcWoOzz0TYZXuNJ9Blg8AeWbg=\" rel=\"nofollow\" target=\"_blank\">Virtual Investor Closing Bell<\/a> event on Tuesday, July 14, 2026, at 4:00 PM ET.<\/p>\n<p align=\"justify\">For the segment, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=q-15JC3leebqYvLo_dlUp6w_r9vDArXC5obHwcx2zeZE484aMu7t1_vQ5r_LOiqsYtnpX0-mtkxLHkXXT51CT2I8Gk1PyJjpDyMlb1sB3Z3gaw9oGjmTxLkXDIwglZfj_v5hjs4vl1QY7VBr8AIo3AzgiGKabP_q23SduaiA7Pt-KPEjBG1ztdxp-xmpHxX40tlZvS--_eVomtV8pFAfGw==\" rel=\"nofollow\" target=\"_blank\">Sabrina Martucci Johnson, President and Chief Executive Officer<\/a> of Dar\u00e9 Bioscience, will provide a brief corporate overview highlighting the recent launch of FloraSync LF5\u2122, the Company&#8217;s strategy for thoughtfully building its commercial business while advancing its differentiated women&#8217;s health pipeline, and the milestones that will shape Dar\u00e9&#8217;s long-term growth. The discussion will also provide insight into the Company&#8217;s disciplined approach to capital allocation, commercialization, and execution as it works to create sustainable value for shareholders.<\/p>\n<p align=\"justify\">Additionally, there will be a live question and answer session with audience participants. Ms. Martucci Johnson will answer as many questions as possible in the time allowed.<\/p>\n<p align=\"justify\">A\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=WmSXE5E8CNP-bi-ABbhyL5evx5YZ8lQ-6uMevfBa5dF-3mAmyjMD4Rh3R56X5rtqqisXFjqMIayKilb68OWT6P-Y_3eOldGfiMuoSFmFRx1LskhUfb8Kx9lXFV83a5TPvo5Y2XSGoS5rsGeE5zRplR72MTHpPTNE2B-Sm46hbZQ=\" rel=\"nofollow\" target=\"_blank\">live video webcast<\/a>\u00a0will be available on the\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=MABVE22hTv6qQiVsriMtfQjGAnN8iNpDcR9y-ss1zyYBLcdvqApevvO7YxWOetprvdMhNsakq4Ogq8_jIww9_4YsbjadfdbmSVg0r2o3MuUFB7vs7z_XY-Jz3bV1OPuuH8vD3OZI5ox_eI6G0K570X9ylzx15TalOFO9dtLZWYQ=\" rel=\"nofollow\" target=\"_blank\">Presentations, Events &amp; Webcasts<\/a>\u00a0page of the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=kdNxP3nfGUHibdHGxXZfTntjBfXyVypms9x579cqrMm4dbU2kAQvlGdHuUeFzhZ969d2VAD9RY1Stgp5FA14EBi-efIfky1bOxToy4kFiCk=\" rel=\"nofollow\" target=\"_blank\">Investors section<\/a> of the Company\u2019s website (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Vxtwy2BMchPj48mkS6vkthbeljP8xNUBuIii3g7oUNT9c6xFRKvJe8LHWt3kTmzHfXuOfVXQT4p0uzy3uyCwE92b4ThvTjkcrnxSlesLpaU=\" rel=\"nofollow\" target=\"_blank\">darebioscience.com<\/a>). A webcast replay will become available approximately two hours following the live event and will be accessible in the same section of the Company\u2019s website for 90 days.<\/p>\n<p align=\"justify\">\n        <strong><br \/>\n          <u>ABOUT DAR\u00c9 BIOSCIENCE, INC.<\/u><br \/>\n        <\/strong>\n      <\/p>\n<p align=\"justify\">Dar\u00e9 Bioscience (NASDAQ: DARE) is a purpose-driven health biotech company solely focused on closing the gap in women\u2019s health between promising science and real-world solutions. Every innovation Dar\u00e9 advances is based in advanced science and backed by rigorous, peer-reviewed research. From contraception to menopause, sexual health to fertility, vaginal health to infectious disease, Dar\u00e9 is working to close critical gaps in care using science that serves her needs. For decades, women have been told to \u201cwait it out\u201d or \u201clive with it,\u201d while innovations that could improve their quality of life languish in the regulatory or funding pipeline. With growing awareness around menopause, sexual health, and vaginal health, the conversation is shifting. However, access to proven solutions is lagging. Dar\u00e9 is working to change that. Learn more at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Vxtwy2BMchPj48mkS6vkth_cirN6FfKqBXGgsvObwA8PxvpvkgTiAUX8uPTfBZSZsONfd-TuBkdGdi26m_uyNcEWipWgj6wDg4VWw_dOub4=\" rel=\"nofollow\" target=\"_blank\">darebioscience.com<\/a>.<\/p>\n<p>\n        <strong>Contact:<\/strong><br \/>\n        <br \/>\n        <strong>Dar\u00e9 Bioscience Investor Relations<\/strong><br \/>\n        <br \/>innovations@darebioscience.com<br \/><em>Source: Dar\u00e9 Bioscience, Inc.<\/em><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc1OTQ0NCM3Njk4MTExIzIwMDgzNjQ=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/YzI2NmQ1YzYtYmVhYS00YTAxLTk2NjYtNzI5YmY2MjljYjEyLTEwMTk5MzctMjAyNi0wNy0wOS1lbg==\/tiny\/Dar-Bioscience-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Live video webcast on Tuesday, July 14 th , at 4:00 PM ET Register here SAN DIEGO, July 09, 2026 (GLOBE NEWSWIRE) &#8212; Dar\u00e9 Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women&#8217;s health between promising science and real-world solutions, today announced that it will participate in a Virtual Investor Closing Bell event on Tuesday, July 14, 2026, at 4:00 PM ET. For the segment, Sabrina Martucci Johnson, President and Chief Executive Officer of Dar\u00e9 Bioscience, will provide a brief corporate overview highlighting the recent launch of FloraSync LF5\u2122, the Company&#8217;s strategy for thoughtfully building its commercial business while advancing its differentiated women&#8217;s health pipeline, and the milestones that will shape Dar\u00e9&#8217;s &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-ceo-sabrina-martucci-johnson-to-participate-in-virtual-investor-closing-bell-event\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Dar\u00e9 Bioscience CEO, Sabrina Martucci Johnson, to Participate in Virtual Investor Closing Bell Event&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-980186","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Dar\u00e9 Bioscience CEO, Sabrina Martucci Johnson, to Participate in Virtual Investor Closing Bell Event - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-ceo-sabrina-martucci-johnson-to-participate-in-virtual-investor-closing-bell-event\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dar\u00e9 Bioscience CEO, Sabrina Martucci Johnson, to Participate in Virtual Investor Closing Bell Event - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Live video webcast on Tuesday, July 14 th , at 4:00 PM ET Register here SAN DIEGO, July 09, 2026 (GLOBE NEWSWIRE) &#8212; Dar\u00e9 Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women&#8217;s health between promising science and real-world solutions, today announced that it will participate in a Virtual Investor Closing Bell event on Tuesday, July 14, 2026, at 4:00 PM ET. For the segment, Sabrina Martucci Johnson, President and Chief Executive Officer of Dar\u00e9 Bioscience, will provide a brief corporate overview highlighting the recent launch of FloraSync LF5\u2122, the Company&#8217;s strategy for thoughtfully building its commercial business while advancing its differentiated women&#8217;s health pipeline, and the milestones that will shape Dar\u00e9&#8217;s &hellip; Continue reading &quot;Dar\u00e9 Bioscience CEO, Sabrina Martucci Johnson, to Participate in Virtual Investor Closing Bell Event&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-ceo-sabrina-martucci-johnson-to-participate-in-virtual-investor-closing-bell-event\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-09T12:46:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc1OTQ0NCM3Njk4MTExIzIwMDgzNjQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dare-bioscience-ceo-sabrina-martucci-johnson-to-participate-in-virtual-investor-closing-bell-event\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dare-bioscience-ceo-sabrina-martucci-johnson-to-participate-in-virtual-investor-closing-bell-event\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Dar\u00e9 Bioscience CEO, Sabrina Martucci Johnson, to Participate in Virtual Investor Closing Bell Event\",\"datePublished\":\"2026-07-09T12:46:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dare-bioscience-ceo-sabrina-martucci-johnson-to-participate-in-virtual-investor-closing-bell-event\\\/\"},\"wordCount\":382,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dare-bioscience-ceo-sabrina-martucci-johnson-to-participate-in-virtual-investor-closing-bell-event\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc1OTQ0NCM3Njk4MTExIzIwMDgzNjQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dare-bioscience-ceo-sabrina-martucci-johnson-to-participate-in-virtual-investor-closing-bell-event\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dare-bioscience-ceo-sabrina-martucci-johnson-to-participate-in-virtual-investor-closing-bell-event\\\/\",\"name\":\"Dar\u00e9 Bioscience CEO, Sabrina Martucci Johnson, to Participate in Virtual Investor Closing Bell Event - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dare-bioscience-ceo-sabrina-martucci-johnson-to-participate-in-virtual-investor-closing-bell-event\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dare-bioscience-ceo-sabrina-martucci-johnson-to-participate-in-virtual-investor-closing-bell-event\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc1OTQ0NCM3Njk4MTExIzIwMDgzNjQ=\",\"datePublished\":\"2026-07-09T12:46:01+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dare-bioscience-ceo-sabrina-martucci-johnson-to-participate-in-virtual-investor-closing-bell-event\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dare-bioscience-ceo-sabrina-martucci-johnson-to-participate-in-virtual-investor-closing-bell-event\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dare-bioscience-ceo-sabrina-martucci-johnson-to-participate-in-virtual-investor-closing-bell-event\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc1OTQ0NCM3Njk4MTExIzIwMDgzNjQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc1OTQ0NCM3Njk4MTExIzIwMDgzNjQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dare-bioscience-ceo-sabrina-martucci-johnson-to-participate-in-virtual-investor-closing-bell-event\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Dar\u00e9 Bioscience CEO, Sabrina Martucci Johnson, to Participate in Virtual Investor Closing Bell Event\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Dar\u00e9 Bioscience CEO, Sabrina Martucci Johnson, to Participate in Virtual Investor Closing Bell Event - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-ceo-sabrina-martucci-johnson-to-participate-in-virtual-investor-closing-bell-event\/","og_locale":"en_US","og_type":"article","og_title":"Dar\u00e9 Bioscience CEO, Sabrina Martucci Johnson, to Participate in Virtual Investor Closing Bell Event - Market Newsdesk","og_description":"Live video webcast on Tuesday, July 14 th , at 4:00 PM ET Register here SAN DIEGO, July 09, 2026 (GLOBE NEWSWIRE) &#8212; Dar\u00e9 Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women&#8217;s health between promising science and real-world solutions, today announced that it will participate in a Virtual Investor Closing Bell event on Tuesday, July 14, 2026, at 4:00 PM ET. For the segment, Sabrina Martucci Johnson, President and Chief Executive Officer of Dar\u00e9 Bioscience, will provide a brief corporate overview highlighting the recent launch of FloraSync LF5\u2122, the Company&#8217;s strategy for thoughtfully building its commercial business while advancing its differentiated women&#8217;s health pipeline, and the milestones that will shape Dar\u00e9&#8217;s &hellip; Continue reading \"Dar\u00e9 Bioscience CEO, Sabrina Martucci Johnson, to Participate in Virtual Investor Closing Bell Event\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-ceo-sabrina-martucci-johnson-to-participate-in-virtual-investor-closing-bell-event\/","og_site_name":"Market Newsdesk","article_published_time":"2026-07-09T12:46:01+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc1OTQ0NCM3Njk4MTExIzIwMDgzNjQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-ceo-sabrina-martucci-johnson-to-participate-in-virtual-investor-closing-bell-event\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-ceo-sabrina-martucci-johnson-to-participate-in-virtual-investor-closing-bell-event\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Dar\u00e9 Bioscience CEO, Sabrina Martucci Johnson, to Participate in Virtual Investor Closing Bell Event","datePublished":"2026-07-09T12:46:01+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-ceo-sabrina-martucci-johnson-to-participate-in-virtual-investor-closing-bell-event\/"},"wordCount":382,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-ceo-sabrina-martucci-johnson-to-participate-in-virtual-investor-closing-bell-event\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc1OTQ0NCM3Njk4MTExIzIwMDgzNjQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-ceo-sabrina-martucci-johnson-to-participate-in-virtual-investor-closing-bell-event\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-ceo-sabrina-martucci-johnson-to-participate-in-virtual-investor-closing-bell-event\/","name":"Dar\u00e9 Bioscience CEO, Sabrina Martucci Johnson, to Participate in Virtual Investor Closing Bell Event - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-ceo-sabrina-martucci-johnson-to-participate-in-virtual-investor-closing-bell-event\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-ceo-sabrina-martucci-johnson-to-participate-in-virtual-investor-closing-bell-event\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc1OTQ0NCM3Njk4MTExIzIwMDgzNjQ=","datePublished":"2026-07-09T12:46:01+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-ceo-sabrina-martucci-johnson-to-participate-in-virtual-investor-closing-bell-event\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-ceo-sabrina-martucci-johnson-to-participate-in-virtual-investor-closing-bell-event\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-ceo-sabrina-martucci-johnson-to-participate-in-virtual-investor-closing-bell-event\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc1OTQ0NCM3Njk4MTExIzIwMDgzNjQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc1OTQ0NCM3Njk4MTExIzIwMDgzNjQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-ceo-sabrina-martucci-johnson-to-participate-in-virtual-investor-closing-bell-event\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Dar\u00e9 Bioscience CEO, Sabrina Martucci Johnson, to Participate in Virtual Investor Closing Bell Event"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/980186","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=980186"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/980186\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=980186"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=980186"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=980186"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}